From Hedge Force to Source of Risk: IMF Lists AI Boom Alongside Oil and Debt as a “Risk Portfolio” for the First Time
The International Monetary Fund (IMF) is redefining the qualitative assessment of the AI boom. On the eve of hosting the Global Economic Heads Conference next week, IMF identifies the “imbalanced AI boom,” the prolonged energy shock, and record-breaking debt accumulation as a collective “risk combination” facing the world, urging governments to take urgent action.
This is the latest statement by IMF President Kristalina Georgieva, with the main highlight being that the surge in capital expenditure on AI is for the first time placed on par with the oil crisis and sovereign debt. Previously, the IMF’s reports considered investments in artificial intelligence and data centers as partial hedges against energy supply shocks triggered by wars in the Middle East. Now, this “hedging power” is newly characterized as one of the sources of risk.
For investors, the policy environment surrounding the AI narrative is undergoing changes. When the IMF begins to see the “imbalanced AI boom” as a source of macro instability, rather than just a productivity story, the urgent calls for government action signal that policy responses regarding AI infrastructure investment, energy supply, and fiscal discipline may be on the agenda.
The core of the IMF’s warning is that the transmission of three overlapping risks could amplify shocks: energy shocks drive inflation and interest rates higher, and rising rates add pressure to debt burdens already near critical levels. Global public debt is projected to surpass 100% of GDP in 2029, two years earlier than previously expected, making the chain even tighter.
AI: From Hedging Power to Source of Risk
In this statement, the role of AI undergoes a critical change. Previously, the IMF noted that investments in artificial intelligence and data centers offset part of the energy shortage’s impact; now, Georgieva refers to the “imbalanced AI boom,” listing it alongside energy shocks and debt accumulation as a global “risk combination.”
This means that the surge in AI capital expenditures is being drawn from the “growth engine” side into discussions as a “source of risk” for the first time. The IMF’s concern is not with AI technology itself, but with its macro spillovers—the interaction of its boom with energy demand and debt financing, which may amplify the destructive power of any single shock.
Debt: To Surpass GDP in 2029, Two Years Ahead of Previous Projections
Debt is the most clearly quantified part of the “risk combination.” Georgieva previously stated at an economic forum in New York that, driven by the rapid uptick in government borrowing by the US and others, global public debt will exceed 100% of global GDP by 2029, two years earlier than prior forecasts.
She candidly said governments had “far from enough action” on fiscal restructuring, and has held dedicated discussions with US Treasury Secretary Scott Bessent on America’s fiscal issues. Both parties agree that the current US debt structure is unsustainable.
Growth and Inflation Facing Dual Pressure
Warning signs have already emerged at a more macro level. The IMF has lowered its global economic growth forecast twice this year, with the latest projection indicating that growth will drop to 3.0% by 2026. The overall inflation rate in OECD member countries has recently climbed to a two-year high.
High energy prices and sticky inflation reinforce expectations that central banks worldwide will tighten policy in unison. Against this backdrop, the IMF has identified the AI boom, energy shock, and debt accumulation as a “risk combination,” and has chosen to issue this warning ahead of the global economic summit next week, highlighting the urgency of policy coordination.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ - Reports claim Intel is still involved in Elon Musk's Terafab project, prompting a surge in its stock price
Latest update October 7 - Chipmaker Intel (INTC.O) shares rose 0.84% to $113.45 in premarket trading, attempting a rebound after four consecutive days of decline. Intel (INTC) CEO Pat Gelsinger told Bloomberg (link) the company will continue to advance Elon Musk's Terafab chip manufacturing (link) project. The report was released just days after Musk said TSMC 2330.TW and Terafab had discussed potential collaboration (link). Terafab is Elon Musk’s planned chip manufacturing plant (link), aiming to produce AI chips for Tesla TSLA.O and SpaceX SPCX.O. Last Saturday, Musk said that discussions were still at a preliminary stage and added that there may be results. However, on Wednesday he stated that TSMC (link) would not operate the Terafab AI chip production facility. Intel and Tesla did not immediately respond to Reuters' request for comment outside regular business hours. As of the close of the previous trading day, Intel (INTC) shares had more than tripled year to date. The stock dropped a total of 6.4% over the last four trading sessions. Meanwhile, shares of other major chipmakers declined, with Nvidia NVDA.O and AMD AMD.O dropping 0.6% and 1.8%, respectively. (For the convenience of non-English speakers, Reuters automates the translation of its reports into several other languages. As automated translations may contain errors or lack required context, Reuters does not guarantee the accuracy of automated translated texts. Automated translations are provided solely to assist readers. Reuters does not accept any liability for damage or loss resulting from the use of automated translation services.)
Exclusive Report - Sources say Apollo has submitted a non-binding offer for German energy company Uniper
Christoph Steitz/Anousha Sakoui – Reuters, Frankfurt/London, October 7 – According to two directly informed sources, Apollo Global Management (APO.N) has submitted a non-binding offer for the German state-owned energy company Uniper (UN0k.DE), joining the bidding for one of Germany’s largest utility companies. Prospective buyers must submit expressions of interest for Uniper by September 21. The company received a €13.5 billion ($15.1 billion) bailout from the Berlin government in 2022. Reuters previously reported that the sale of Uniper could be valued at around €10 billion, making it one of the largest utility transactions in Europe this year. The German Ministry of Finance, which oversees the Berlin government’s 99.12% stake in Uniper, is advised by UBS and JPMorgan, and has stated that it plans to sell up to 74.12% of the energy company. Czech energy company EPH, controlled by billionaire Daniel Kretinsky, as well as a consortium consisting of Brookfield (BN.TO) and Canadian CPPIB, have also submitted Expressions of Interest, Reuters previously reported. One source said Norway’s Equinor (EQNR.OL), as well as a consortium made up of KKR (KKR.N) and German rival RWE (RWEG.DE), have also placed offers. A third source involved in the negotiations stated that bidders are expected to be informed in the coming weeks whether they will advance to the next round. These individuals requested anonymity as they are not authorized to speak publicly. Apollo, Uniper, and KKR all declined to comment. Equinor has so far not commented. (1 USD = 0.8933 EUR) (For the convenience of non-English readers, Reuters automatically translates its reports into several other languages. Since automated translation may be inaccurate or miss relevant context, Reuters does not guarantee translation accuracy and provides these as a convenience only. Reuters is not liable for damage or loss resulting from the use of automated translation.)
BUZZ - Vaxcyte shares dip slightly after raising 1 billion dollars for pneumococcal vaccine development
On October 7: Vaxcyte (PCVX.O) shares fell 0.3% in premarket trading on Wednesday to $66.50, after the company completed a $1.1 billion financing round. On Tuesday night, PCVX announced the pricing (link) of approximately 7.8 million shares of common stock and pre-funded warrants at $64 per share, raising $500 million in total; simultaneously, the company launched a public offering of $500 million of convertible senior notes with a coupon rate of 1.5%, maturing on October 15, 2032. The conversion price of the convertible notes is $89.60, representing a 40% premium over the equity offering price. On Monday, PCVX shares surged around 31% after the company announced that its pneumococcal vaccine VAX-31 met all primary endpoints in late-stage clinical trials (link), generating an immune response at least comparable to that of Pfizer’s Prevnar 20 (PFE.N) and Merck’s Capvaxive (MRK.N). On Tuesday, following the launch of the public offering (link), the stock closed down nearly 10% at $66.70. PCVX plans to use the net proceeds from this offering to fund clinical development of the VAX-31 adult and pediatric programs, including the ongoing adult Phase III clinical trial of VAX-31. Jefferies, Leerink, BofA, Evercore, Goldman Sachs, and Guggenheim are joint book-running managers for the equity offering; Jefferies, Leerink, BofA, Goldman Sachs, and Evercore act as lead managers for the convertible notes transaction. As of Tuesday’s close, PCVX shares are up about 45% year-to-date.
BUZZ - Cantor upgrades Humana rating, expects its Medicare profit margin to rebound strongly in 2027
October 7 - Cantor Fitzgerald has upgraded its rating on health insurance company Humana (HUM.N) from "Neutral" to "Overweight" and raised the target price from $300 to $460. The brokerage increased its 2027 EPS estimate from $15.86 to $17.96 and its 2028 estimate from $25.38 to $28.27, citing increased confidence in HUM's margin performance and quality rating recovery within the Medicare Advantage plan. Cantor expects this week’s upcoming Medicare quality ratings to be positive, and better scores would help HUM secure higher government bonuses in 2028. The brokerage stated that pricing strategies, benefits adjustments, and measures to control medical costs are expected to significantly improve Medicare margins in 2027. It believes that confirmation of HUM's 2027 performance forecast and 2027 membership in line with expectations will be the next potential catalyst following the quality ratings release. Cantor noted that HUM currently trades at 9.9 times management’s midpoint 2028 earnings forecast, compared to a historical average P/E of about 18x. (For the convenience of non-English speakers, Reuters may provide automated translations of its report into multiple languages. Due to possible errors or lack of appropriate context, Reuters does not guarantee the accuracy of translated text and provides automated translations solely for reader convenience. Reuters assumes no responsibility for any damage or loss resulting from the use of automated translation functions.)
Crypto prices
More
